首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >CXCR7 expression in nasopharyngeal carcinoma tissues correlates with disease severity
【2h】

CXCR7 expression in nasopharyngeal carcinoma tissues correlates with disease severity

机译:鼻咽癌组织中CXCR7的表达与疾病的严重程度有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The chemokine CXCL12 and its receptors, CXCR4 and CXCR7, are important contributors to the pathogenesis of multiple types of tumors. CXCL12/CXCR4 was previously demonstrated to be upregulated in nasopharyngeal carcinoma (NPC) tissues, but the status of CXCR7 in NPC remains unknown. Here, 62 nasopharyngeal carcinoma specimens were obtained from patients who received rhinitis biopsy in our hospital in 2012 and 2013. Another 30 samples were collected from patients with nasopharyngitis who did not have NPC, to serve as a control group. Expression of CXCR7 protein and mRNA in NPC and normal tissues was detected by immunohistochemistry and quantitative real-time polymerase chain reaction, respectively. CXCR7 protein was detected in just 7.1% (2/30) of normal nasopharyngeal samples, but 61.3% (38/62) of tumor tissues (P<0.05). The staining patterns (proportion of stained cells/sample as well as staining intensity) were correlated with lymph node metastasis, TNM staging, and disease severity (P<0.01). Thus, CXCR7 may promote disease progression in nasopharyngeal carcinoma, and may be useful as a predictor of metastasis and prognosis.
机译:趋化因子CXCL12及其受体CXCR4和CXCR7是导致多种类型肿瘤发生的重要因素。先前已证明CXCL12 / CXCR4在鼻咽癌(NPC)组织中被上调,但是CXCR7在NPC中的状态仍然未知。在这里,我们分别于2012年和2013年从我院接受鼻炎活检的患者中采集了62份鼻咽癌标本。另从无NPC的鼻咽炎患者中收集了30份样品作为对照组。通过免疫组织化学和定量实时聚合酶链反应分别检测NPC和正常组织中CXCR7蛋白和mRNA的表达。在正常鼻咽样本中仅检测到7.1%(2/30)的CXCR7蛋白,但是在肿瘤组织中检测到61.3%(38/62)的CXCR7蛋白(P <0.05)。染色模式(染色细胞/样品的比例以及染色强度)与淋巴结转移,TNM分期和疾病严重程度相关(P <0.01)。因此,CXCR7可以促进鼻咽癌的疾病进展,并且可以用作转移和预后的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号